cdmo.directory
← Compare landing

IDT Australia vs Sai Life Sciences

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/idtaus-com/sailife

CategoryIDT AustraliaSai Life Sciences
Listed sitecdmocdmo
SummaryIDT Australia is a cGMP CDMO delivering end-to-end pharmaceutical development and manufacturing services from active pharmaceutical ingredients to finished dosage forms, with expertise in small molecule APIs, specialty orals, advanced therapies, and integrated regulatory support.Integrated CRDMO offering discovery, development, and manufacturing services for small molecule NCE programs across 280+ global pharma and biotech clients.
Services
  • HPAPI Manufacturing (High-Potency)
  • Process Development
  • Secondary Packaging & Labeling
  • API Synthesis & Manufacturing
  • Small Molecule Development & Manufacturing
  • ADC Payload & Linker Synthesis
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • Formulation Development
  • Oral Solid Dosage Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Vial Filling
  • Lyophilization (Freeze Drying)
  • CMC Analytical Development
  • Stability Testing & Storage
  • Quality Control Testing
  • Regulatory Affairs
  • CMC Regulatory Submission Support
  • Technology Transfer
  • CMC Analytical Development
  • Process Development
  • Stability Testing & Storage
  • Technology Transfer
  • API Synthesis & Manufacturing
  • Small Molecule Development & Manufacturing
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • ADC Payload & Linker Synthesis
  • Flow Chemistry & Continuous Manufacturing
  • CMC Regulatory Submission Support
  • Solid-State Chemistry & Polymorph Screening
  • Formulation Development
  • Quality Control Testing
Modalities
  • Small Molecule
  • Antibody-Drug Conjugate (ADC)
  • Radiopharmaceutical
  • Small Molecule
  • Antibody-Drug Conjugate (ADC)
Indications
  • Neurology
  • Metabolic
  • Ophthalmology
Data not yet provided.
Locations
  • Headquarters, Australia
  • Headquarters, India, India
  • UK Office, UK, United Kingdom
  • USA Office, USA, United States
  • Boston Laboratory, Boston, Massachusetts, USA
  • Headquarters, Hyderabad, Telangana, India
  • Bidar Campus (Unit IV & VI), Bidar, Karnataka, India
  • Boston, Boston, Massachusetts, USA
  • UK Facility, United Kingdom
  • UK Operations, United Kingdom
  • Bidar Campus (API Manufacturing), Bidar, Karnataka, India
  • Integrated R&D Campus, Hyderabad, Telangana, India
  • Boston Area Site, Boston, Massachusetts, USA
CertificationsData not yet provided.
  • USFDA · Identifier: 21 CFR Part 210 and 211
  • EU · Identifier: EU cGMP guidelines
  • TGA · Identifier: TGA guidelines
  • India · Identifier: Schedule M (Indian cGMP standards)
  • My Green Lab (MGL) · Identifier: Green Lab Certification (98%+ compliance score)
  • BSE · Identifier: 544306
  • NSE · Identifier: SAILIFE
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.